Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1057.00 | 1069.00 | 0.9888 | 0.9761 | |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 843.00 | 1069.00 | 0.7886 | 0.5537 | |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 801.00 | 1069.00 | 0.7493 | 0.4715 | |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1127.00 | 1069.00 | 1.0543 | 1.1156 | |
SK-BR-3 | PLX-4720 | 19.9526 | uM | 3 | 625.00 | 556.96 | 940.00 | 1069.00 | 0.8793 | 0.7444 |
SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 625.00 | 556.96 | 1141.00 | 1069.00 | 1.0674 | 1.1435 |
SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1406.00 | 1069.00 | 1.3152 | 1.6764 |
SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 625.00 | 556.96 | 1250.00 | 1069.00 | 1.1693 | 1.3618 |
SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 625.00 | 556.96 | 1306.00 | 1069.00 | 1.2217 | 1.4745 |
SK-BR-3 | Nilotinib | 0.31623 | uM | 3 | 625.00 | 556.96 | 1337.00 | 1069.00 | 1.2507 | 1.5370 |
SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1241.00 | 1069.00 | 1.1609 | 1.3438 |
SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 625.00 | 556.96 | 1348.00 | 1069.00 | 1.2610 | 1.5592 |
SK-BR-3 | NVP-TAE684 | 0.1 | uM | 3 | 625.00 | 556.96 | 1028.00 | 1069.00 | 0.9617 | 0.9186 |
SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 625.00 | 556.96 | 1375.00 | 1069.00 | 1.2862 | 1.6137 |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1270.00 | 1069.00 | 1.1880 | 1.4020 | |
SK-BR-3 | Nilotinib | 0.01 | uM | 3 | 625.00 | 556.96 | 1340.00 | 1069.00 | 1.2535 | 1.5430 |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 1109.00 | 1069.00 | 1.0374 | 1.0797 | |
SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 3 | 625.00 | 556.96 | 1155.00 | 1069.00 | 1.0804 | 1.1715 |
SK-BR-3 | Etoposide | 0.01 | uM | 3 | 625.00 | 556.96 | 935.00 | 1069.00 | 0.8747 | 0.7346 |
SK-BR-3 | Etoposide | 1 | uM | 3 | 625.00 | 556.96 | 661.00 | 1069.00 | 0.6183 | 0.1997 |
SK-BR-3 | PLX-4720 | 10 | uM | 3 | 625.00 | 556.96 | 1255.00 | 1069.00 | 1.1740 | 1.3719 |
SK-BR-3 | Etoposide | 10 | uM | 3 | 625.00 | 556.96 | 442.00 | 1069.00 | 0.4135 | -0.2179 |
SK-BR-3 | Nilotinib | 0.0033113 | uM | 3 | 625.00 | 556.96 | 1057.00 | 1069.00 | 0.9888 | 0.9761 |
SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 625.00 | 556.96 | 917.00 | 1069.00 | 0.8578 | 0.6991 |
SK-BR-3 | 0 | uM | 3 | 625.00 | 556.96 | 983.00 | 1069.00 | 0.9196 | 0.8294 |